Regenerative medicine company KeraNetics, whose biomaterials research into healing damaged tissue is already in the U.S. military’s sights, is now raising a targeted $7 million in equity financing.
The Winston-Salem, North Carolina company has raised $4.7 million from 26 investors so far in a securities sale that began on Dec. 30, according to securities filings.
KeraNetics is based on technology developed at Wake Forest University‘s Institute for Regenerative Medicine. The company works with keratins, a class of fibrous structural proteins that make up the hair, the outer layer of the skin and fingernails.
Really gorgeous site structure and color method. Do you find yourself an artist by way of job? Your websites furthermore plenty really quick. You may have generated your own long-term reader
ReplyDelete